|
DYNC1LI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.184160E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.716070E-02 |
| Normal-vs-Stage2 |
9.332000E-02 |
| Normal-vs-Stage3 |
2.42229999999344E-05 |
| Normal-vs-Stage4 |
9.227700E-02 |
| Stage1-vs-Stage2 |
6.250800E-01 |
| Stage1-vs-Stage3 |
1.447710E-02 |
| Stage1-vs-Stage4 |
7.060600E-01 |
| Stage2-vs-Stage3 |
4.450600E-01 |
| Stage2-vs-Stage4 |
8.816200E-01 |
| Stage3-vs-Stage4 |
2.907400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.0677000000009E-05 |
| Normal-vs-AfricanAmerican |
8.965400E-01 |
| Normal-vs-Asian |
6.977000E-01 |
| Caucasian-vs-AfricanAmerican |
4.861900E-02 |
| Caucasian-vs-Asian |
2.975600E-02 |
| AfricanAmerican-vs-Asian |
7.211600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.444550E-03 |
| Normal-vs-Female |
3.477700E-03 |
| Male-vs-Female |
5.258800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.536590E-01 |
| Normal-vs-Age(41-60Yrs) |
2.368400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.199700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.082200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.130000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.053600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.482800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.833800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.578800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.173200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.562400E-01 |
| Classical-VS-Follicular |
8.591600E-01 |
| Classical-VS-Other |
9.138600E-01 |
| Classical-VS-Normal |
6.256500E-03 |
| Tall-VS-Follicular |
2.352800E-01 |
| Tall-VS-Other |
6.012000E-01 |
| Tall-VS-Normal |
2.503100E-03 |
| Follicular-VS-Other |
8.856800E-01 |
| Follicular-VS-Normal |
8.922400E-02 |
| Other-VS-Normal |
1.873170E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.203300E-04 |
| Normal-vs-N1 |
3.427600E-02 |
| N0-vs-N1 |
9.833400E-01 |
|
|
